BUTORPHANOL TARTRATE---DEA SCHEDULE IV

Biochem/physiol Actions

κ/μ opioid receptor agonist.

Features and Benefits

This compound was developed by Bristol-Myers Squibb. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Shipping Information:

Dry Ice Surcharge & Ice Pack Shipments: $40

More Information: https://cenmed.com/shipping-returns

UPC:

51293014

Condition:

New

Weight:

1.00 Ounces

HazmatClass:

No

Quantity:

100

Unit of Measurement:

MG

MPN:

B9156-100MG

CAS:

58786-99-5

Temperature Control Device:

Yes

DEA:

Yes

Controlled Substances and Cyanide:

Yes